About: Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayo clínico (es) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD (en)
skos:prefLabel	Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD (en)
name	Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD (en)
title	wds:Q61980350-80DD6019-2363-4059-AF38-BACB65FD4183
title	A Phase IIIb, Long-Term, Open-Label, Multi-Center, Extension Study Designed to Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) (en)
end time	wds:Q61980350-B14B2B4E-9784-479E-9105-834494747B6B
end time	2009-02-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q61980350-9D804CA2-A2CC-4EE9-9E8C-04330DAE14C1
instance of	clinical trial
start time	wds:Q61980350-814D4736-CACB-4BDF-B1DC-A3DA42FC38FA
start time	2007-08-01 00:00:00Z (xsd:dateTime)
country	wds:Q61980350-41A8E54A-2D02-458C-BF0B-56B08C31F1E1
country	United States of America
research site	wds:Q61980350-7B67EDD7-8617-420A-B2D8-4EA357A05CDD wds:Q61980350-81D8E6D9-41DB-422D-A49D-0B1D969572F5 wds:Q61980350-A13840E8-F58A-4246-B9E5-E7E24A831890 wds:Q61980350-EA0CB008-DD96-432A-8377-7979FF66009A
research site	Rhode Island Hospital CNS Healthcare Northwest Clinical Research Center Rochester Center for Behavioral Medicine
research intervention	wds:Q61980350-E1E0AA84-EE24-4E9B-AE0B-52237E38E4CB
research intervention	methylphenidate
minimum age	wds:Q61980350-59B582C0-0526-4F19-9608-33AE86371F71
minimum age	13 (xsd:decimal)
number of participants	wds:Q61980350-1C482D2B-05F5-43E3-AB0D-DD9084A0432B
number of participants	163 (xsd:decimal)
maximum age	wds:Q61980350-4E344496-FE98-40C5-A740-9CE367058EC6
maximum age	17 (xsd:decimal)
study type	wds:Q61980350-FE7320DE-B89A-43A6-9E6A-8598CF4C1F26
study type	interventional study
ClinicalTrials.gov ID	wds:Q61980350-FEB6FB0C-6401-4034-954E-672BD862F5A3
ClinicalTrials.gov ID	NCT00501293
clinical trial phase	wds:Q61980350-372F5AD3-50D2-4B31-8522-AFB49AEC48DB
clinical trial phase	phase III clinical trial
research subject recruitment status	wds:Q61980350-7E45E164-BEE0-46B1-802E-FA5B5820621F
research subject recruitment status	completed
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61980350

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software